{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T15:03:44Z","timestamp":1776179024137,"version":"3.50.1"},"reference-count":46,"publisher":"American Society of Hematology","issue":"26","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,6,25]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>MicroRNA (miRNA) deregulation contributes to cancer pathogenesis. However, analysis of miRNAs in diffuse large B-cell lymphoma (DLBCL) has been hindered by a focus on cell lines, limited number of miRNAs examined, and lack of copy number data. To address these restrictions, we investigated genomewide miRNA expression and copy number data in 86 DLBCLs. Permutation analysis showed that 63 miRNAs were recurrently disrupted in DLBCL, including highly expressed oncomirs not previously linked to chromosomal abnormalities. Further, using training and validation tumor groups, we defined a collection of miRNAs that robustly segregates DLBCLs into 3 subsets, which are independent of the cell-of-origin classification, extent of T-cell infiltrate, and tumor site. Instead, these unique miRNA-driven DLBCL subgroups showed markedly different MYC transcriptional activity, which explained the dominance of miRNAs regulated by MYC in their expression signatures. In addition, analysis of miRNA expression patterns of normal B cells and integration of copy number and expression data showed that genomic abnormalities and the genetic fingerprint of nonmalignant cells also contribute to the miRNA profile of DLBCL. In conclusion, we created a comprehensive map of the miRNA genome in DLBCL and, in the process, have uncovered and mechanistically elucidated the basis for additional molecular heterogeneity in this tumor.<\/jats:p>","DOI":"10.1182\/blood-2009-01-202028","type":"journal-article","created":{"date-parts":[[2009,3,11]],"date-time":"2009-03-11T02:39:06Z","timestamp":1236739146000},"page":"6681-6690","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":62,"title":["Copy number abnormalities, MYC activity, and the genetic fingerprint of normal B cells mechanistically define the microRNA profile of diffuse large B-cell lymphoma"],"prefix":"10.1182","volume":"113","author":[{"given":"Cheng","family":"Li","sequence":"first","affiliation":[{"name":"Department of Biostatistics, Harvard School of Public Health, Boston, MA; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Woo","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Hematology and Medical Oncology, Cancer Therapy and Research Center, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak","family":"Rai","sequence":"additional","affiliation":[{"name":"Division of Hematology and Medical Oncology, Cancer Therapy and Research Center, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aswani R.","family":"Bolla","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Texas Health Science Center at San Antonio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siddharth","family":"Adhvaryu","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Texas Health Science Center at San Antonio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marsha C.","family":"Kinney","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Texas Health Science Center at San Antonio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan S.","family":"Robetorye","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Texas Health Science Center at San Antonio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo C. T.","family":"Aguiar","sequence":"additional","affiliation":[{"name":"Division of Hematology and Medical Oncology, Cancer Therapy and Research Center, and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2019111721294591000_B1","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1182\/blood-2005-02-0687","article-title":"Advances in the biology and therapy of diffuse large B-cell lymphoma-moving towards a molecularly targeted approach.","volume":"106","author":"Abramson","year":"2005","journal-title":"Blood"},{"key":"2019111721294591000_B2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrc1840","article-title":"Oncomirs - microRNAs with a role in cancer.","volume":"6","author":"Esquela-Kerscher","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"2019111721294591000_B3","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1182\/blood-2008-10-184077","article-title":"Differentiation-stage-specific expression of micro-RNAs in B-lymphocytes and diffuse large B-cell lymphomas.","volume":"113","author":"Malumbres","year":"2009","journal-title":"Blood"},{"key":"2019111721294591000_B4","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1365-2141.2008.07237.x","article-title":"MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas.","volume":"142","author":"Roehle","year":"2008","journal-title":"Br J Haematol"},{"key":"2019111721294591000_B5","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.0307323101","article-title":"Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.","volume":"101","author":"Calin","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111721294591000_B6","unstructured":"Wellcome Trust Sanger Institute Accessed November 25, 2006 miRBase, version 9. http:\/\/microrna.sanger.ac.uk\/"},{"key":"2019111721294591000_B7","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"2019111721294591000_B8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cancergencyto.2007.10.008","article-title":"Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma.","volume":"181","author":"Rai","year":"2008","journal-title":"Cancer Genet Cytogenet"},{"key":"2019111721294591000_B9","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nature03552","article-title":"A microRNA polycistron as a potential human oncogene.","volume":"435","author":"He","year":"2005","journal-title":"Nature"},{"key":"2019111721294591000_B10","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1158\/0008-5472.CAN-03-3773","article-title":"Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma.","volume":"64","author":"Ota","year":"2004","journal-title":"Cancer Res"},{"key":"2019111721294591000_B11","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/ng2003","article-title":"Impaired microRNA processing enhances cellular transformation and tumorigenesis.","volume":"39","author":"Kumar","year":"2007","journal-title":"Nat Genet"},{"key":"2019111721294591000_B12","doi-asserted-by":"crossref","first-page":"13520","DOI":"10.1073\/pnas.0804295105","article-title":"Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways.","volume":"105","author":"Lenz","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111721294591000_B13","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1182\/blood-2005-07-2950","article-title":"Array comparative genomic hybridization reveals genomic copy number changes associated with outcome in diffuse large B-cell lymphomas.","volume":"107","author":"Chen","year":"2006","journal-title":"Blood"},{"key":"2019111721294591000_B14","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1182\/blood-2005-02-0542","article-title":"Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma.","volume":"106","author":"Tagawa","year":"2005","journal-title":"Blood"},{"key":"2019111721294591000_B15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"2019111721294591000_B16","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1182\/blood-2004-07-2947","article-title":"Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response.","volume":"105","author":"Monti","year":"2005","journal-title":"Blood"},{"key":"2019111721294591000_B17","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nature03677","article-title":"c-Myc-regulated microRNAs modulate E2F1 expression.","volume":"435","author":"O'Donnell","year":"2005","journal-title":"Nature"},{"key":"2019111721294591000_B18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/ng.2007.30","article-title":"Widespread microRNA repression by Myc contributes to tumorigenesis.","volume":"40","author":"Chang","year":"2008","journal-title":"Nat Genet"},{"key":"2019111721294591000_B19","doi-asserted-by":"crossref","first-page":"R69","DOI":"10.1186\/gb-2003-4-10-r69","article-title":"An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets.","volume":"4","author":"Zeller","year":"2003","journal-title":"Genome Biol"},{"key":"2019111721294591000_B20","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ccr.2007.04.001","article-title":"HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity.","volume":"11","author":"Zhang","year":"2007","journal-title":"Cancer Cell"},{"key":"2019111721294591000_B21","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.1128\/MCB.00440-07","article-title":"Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1.","volume":"27","author":"Kim","year":"2007","journal-title":"Mol Cell Biol"},{"key":"2019111721294591000_B22","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia.","volume":"99","author":"Calin","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111721294591000_B23","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1093\/nar\/gni178","article-title":"Real-time quantification of microRNAs by stem-loop RT-PCR.","volume":"33","author":"Chen","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"2019111721294591000_B24","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1182\/blood-2007-07-100115","article-title":"SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma.","volume":"111","author":"Chen","year":"2008","journal-title":"Blood"},{"key":"2019111721294591000_B25","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1158\/1078-0432.28.11.1","article-title":"Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling.","volume":"11","author":"Lam","year":"2005","journal-title":"Clin Cancer Res"},{"key":"2019111721294591000_B26","doi-asserted-by":"crossref","first-page":"13134","DOI":"10.1073\/pnas.0706017104","article-title":"The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma.","volume":"104","author":"Juszczynski","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111721294591000_B27","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nm0102-68","article-title":"Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning.","volume":"8","author":"Shipp","year":"2002","journal-title":"Nat Med"},{"key":"2019111721294591000_B28","doi-asserted-by":"crossref","first-page":"9136","DOI":"10.1073\/pnas.0508889103","article-title":"microRNAs exhibit high frequency genomic alterations in human cancer.","volume":"103","author":"Zhang","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111721294591000_B29","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1126\/science.1137999","article-title":"Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation.","volume":"315","author":"Mayr","year":"2007","journal-title":"Science"},{"key":"2019111721294591000_B30","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1158\/0008-5472.CAN-07-2538","article-title":"The promyelocytic leukemia zinc finger-microRNA-221\/-222 pathway controls melanoma progression through multiple oncogenic mechanisms.","volume":"68","author":"Felicetti","year":"2008","journal-title":"Cancer Res"},{"key":"2019111721294591000_B31","doi-asserted-by":"crossref","first-page":"e4029","DOI":"10.1371\/journal.pone.0004029","article-title":"The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice.","volume":"3","author":"Mercatelli","year":"2008","journal-title":"PLoS ONE"},{"key":"2019111721294591000_B32","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1038\/sj.emboj.7601790","article-title":"Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation.","volume":"26","author":"le Sage","year":"2007","journal-title":"EMBO J"},{"key":"2019111721294591000_B33","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1261\/rna.1034808","article-title":"MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis.","volume":"14","author":"Yan","year":"2008","journal-title":"RNA"},{"key":"2019111721294591000_B34","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.4049\/jimmunol.182.3.1325","article-title":"MicroRNA-513 regulates B7-H1 translation and is involved in IFN-gamma-induced B7-H1 expression in cholangiocytes.","volume":"182","author":"Gong","year":"2009","journal-title":"J Immunol"},{"key":"2019111721294591000_B35","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.1182\/blood-2008-11-189407","article-title":"MicroRNA-29c and microRNA-223 downregulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification.","volume":"113","author":"Stamatopoulos","year":"2009","journal-title":"Blood"},{"key":"2019111721294591000_B36","doi-asserted-by":"crossref","first-page":"19849","DOI":"10.1073\/pnas.0706963104","article-title":"The interplay between the master transcription factor PU.1 and miR-424 regulates human monocyte\/macrophage differentiation.","volume":"104","author":"Rosa","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111721294591000_B37","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/gcc.10025","article-title":"Molecular cytogenetic characterization of non-Hodgkin lymphoma cell lines.","volume":"33","author":"Mehra","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"2019111721294591000_B38","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal gene signatures in large-B-cell lymphomas.","volume":"359","author":"Lenz","year":"2008","journal-title":"N Engl J Med"},{"key":"2019111721294591000_B39","doi-asserted-by":"crossref","first-page":"R71","DOI":"10.1186\/gb-2005-6-8-r71","article-title":"MicroRNA profiling of the murine hematopoietic system.","volume":"6","author":"Monticelli","year":"2005","journal-title":"Genome Biol"},{"key":"2019111721294591000_B40","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/ni1575","article-title":"Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes.","volume":"9","author":"Xiao","year":"2008","journal-title":"Nat Immunol"},{"key":"2019111721294591000_B41","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1517\/14728222.12.9.1139","article-title":"Akt as a therapeutic target in cancer.","volume":"12","author":"Steelman","year":"2008","journal-title":"Expert Opin Ther Targets"},{"key":"2019111721294591000_B42","doi-asserted-by":"crossref","first-page":"592","DOI":"10.4161\/cc.7.5.5492","article-title":"Mechanisms of MYC stabilization in human malignancies.","volume":"7","author":"Junttila","year":"2008","journal-title":"Cell Cycle"},{"key":"2019111721294591000_B43","doi-asserted-by":"crossref","first-page":"34725","DOI":"10.1074\/jbc.R600017200","article-title":"The ins and outs of MYC regulation by posttranslational mechanisms.","volume":"281","author":"Vervoorts","year":"2006","journal-title":"J Biol Chem"},{"key":"2019111721294591000_B44","doi-asserted-by":"crossref","first-page":"e3148","DOI":"10.1371\/journal.pone.0003148","article-title":"Serum micro-RNAs are promising novel biomarkers.","volume":"3","author":"Gilad","year":"2008","journal-title":"PLoS ONE"},{"key":"2019111721294591000_B45","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection.","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111721294591000_B46","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1365-2141.2008.07077.x","article-title":"Detection of elevated levels of tumor-associated microRNAs in serum of patients with diffuse large B-cell lymphoma.","volume":"141","author":"Lawrie","year":"2008","journal-title":"Br J Haematol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/113\/26\/6681\/1310826\/zh802609006681.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/113\/26\/6681\/1310826\/zh802609006681.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T10:05:48Z","timestamp":1684922748000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/113\/26\/6681\/26186\/Copy-number-abnormalities-MYC-activity-and-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,25]]},"references-count":46,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2009,6,25]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2009-01-202028","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,25]]}}}